Latest updates for Cancer-Specific Survival

Fresh curated links around cancer-specific survival are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Akeso, Summit cancer drug confirms lung cancer survival benefit
  • New Cancers Among U.S. Cancer Survivors
  • New Survival Calculator Predicts Outcomes in Rare Early-Onset Urinary Tract Cancer

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

biopharmadive.com /1 month ago

Akeso, Summit cancer drug confirms lung cancer survival benefit

A new data cut of a trial pitting ivonescimab, a bispecific antibody, against Merck’s Keytruda showed the new drug helped people live longer.

Read source
bioengineer.org /1 month ago

New Cancers Among U.S. Cancer Survivors

A Second Cancer Has Touched More Than 2.5 Million US Survivors, Study Finds More than 2.5 million people living in the United States after a cancer diagnosis have developed at leas...

Read source
bioengineer.org /1 week ago

New Survival Calculator Predicts Outcomes in Rare Early-Onset Urinary Tract Cancer

Researchers in China have built and validated a statistical survival calculator for young patients with upper tract urothelial carcinoma using SEER registry data.

Read source
aacr.org /1 week ago

Survival From Lung Cancer, Including the Type That Pope Leo XIV Has, Continues to Improve Thanks to Sustained Cancer Res...

Like millions of people, Pope Leo XIV was diagnosed with lung cancer. This disease, though still serious, has also been transformed from one of daunting odds to a surmountable affl...

Read source
healio.com /2 weeks ago

‘Key’ differences in colorectal cancer with liver metastases

Early-onset colorectal cancer with liver-only metastases can have significant differences in biology from late-onset malignancies.A study of nearly 1,700 individuals from Australia...

Read source
bioengineer.org /1 month ago

Radiation After Liver Cancer Surgery Tops Rankings in Global Therapy Analysis

For patients who undergo curative-intent surgery for hepatocellular carcinoma, the operation itself is only half the battle. Even when surgeons remove all visible tumor tissue, the...

Read source
medicalxpress.com /1 month ago

Child cancer groups call for concerted action

It's one of the cruelest ironies in health and medicine. Pediatric sarcomas are among the rarest yet most aggressive forms of childhood cancer and some of the hardest to cure. Wher...

Read source
sciencedaily.com /2 weeks ago

Bowel cancer “melted away” after immunotherapy, then stayed away

A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patient...

Read source
seekingalpha.com /1 month ago

Summit’s ivonescimab cuts death risk by 27% versus Keytruda in lung cancer trial

Read source
bioengineer.org /1 month ago

What influences cancer survivors’ participation in colorectal and breast screening

Cancer survivors face a paradox that has long puzzled oncologists and public health researchers alike. Although they belong to one of the highest-risk groups for developing new pri...

Read source
healio.com /3 weeks ago

Recognizing depression early ‘essential’ after cancer diagnosis

Early intervention may mitigate elevated risk for cancer-specific mortality observed among people with pre-existing depression, according to retrospective findings.Individuals with...

Read source
letlifehappen.com /1 month ago

Survivorship Care Plans: Improving Use and Benefits for Cancer Survivors

By: Jennifer Larson From.oncologynurseadvisor.com More targeted education about survivorship care plans (SCPs) ensures cancer survivors understand the purpose of SCPs and their own...

Read source
japantimes.co.jp /1 month ago

BioNTech lung cancer drug extends survival versus chemotherapy

Patients treated with gotistobart lived for a median 18.5 months, compared with 10 months for those given the standard-of-care chemotherapy.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Cancer-Specific Survival

bioengineer.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

medicalxpress.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

aacr.org

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source